IQVIA Holdings Inc.
IQVHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframePart of the healthcare sector, IQVIA Holdings Inc. (IQV) is listed under Diagnostics & Research. At a $34.42B market cap, IQVIA Holdings Inc. ranks as a large-cap company within healthcare. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Market Cap
$34.42B
Beta
1.20
P/E (TTM)
26.18
P/E (Fwd)
14.56
EPS (TTM)
$7.88
EPS (Fwd)
$14.17
ROE
22.5%
ROA
5.1%
Cash
$2.10B
Total Debt
$16.10B
Free CF
$2.28B
52W Change
28.4%
Annual Financials
Cash vs Debt
IQVIA Holdings Inc. carries $16.10B in total debt against $2.10B in cash reserves — debt is roughly 7.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $2.28B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 22.5% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $14.41B to $16.31B.
IQVIA Holdings Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for IQVIA Holdings Inc. and its sector.